Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfons Gegenhuber

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Herz|December 23, 2003
[Hypertensive emergency and urgence]Alfons Gegenhuber, Kurt Lenz
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 18, 2004
Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart diseaseThomas Mueller, Alfons Gegenhuber, Werner Poelz, et al.
Clinical Chemistry and Laboratory Medicine|April 6, 2004
Biochemical diagnosis of impaired left ventricular ejection fraction--comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP)Thomas Mueller, Alfons Gegenhuber, Werner Poelz, et al.
Clinical Laboratory|April 13, 2004
Comparison of the automated AxSYM and ADVIA centaur immunoassays for homocysteine determinationMeinhard Haltmayer, Thomas Mueller, Alfons Gegenhuber, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 21, 2015
Analytical and clinical evaluation of a rapid quantitative lateral flow immunoassay for measurement of soluble ST2 in human plasmaBenjamin Dieplinger, Margot Egger, Alfons Gegenhuber, et al.
Clinical Chemistry and Laboratory Medicine|September 25, 2004
Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samplesThomas Mueller, Alfons Gegenhuber, Benjamin Dieplinger, et al.
Clinical Biochemistry|March 11, 2009
Prognostic value of increased adiponectin plasma concentrations in patients with acute destabilized heart failureBenjamin Dieplinger, Alfons Gegenhuber, Werner Poelz, et al.
Clinical Chemistry|October 15, 2005
Capability of B-type natriuretic peptide (BNP) and amino-terminal proBNP as indicators of cardiac structural disease in asymptomatic patients with systemic arterial hypertensionThomas Mueller, Alfons Gegenhuber, Benjamin Dieplinger, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 8, 2006
B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failureAlfons Gegenhuber, Thomas Mueller, Benjamin Dieplinger, et al.
Clinical Biochemistry|August 2, 2015
Plasma concentrations of novel cardiac biomarkers before and after hemodialysis sessionThomas Mueller, Alfons Gegenhuber, Gert Kronabethleitner, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Herz|December 23, 2003
[Hypertensive emergency and urgence]Alfons Gegenhuber, Kurt Lenz
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 18, 2004
Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart diseaseThomas Mueller, Alfons Gegenhuber, Werner Poelz, et al.
Clinical Chemistry and Laboratory Medicine|April 6, 2004
Biochemical diagnosis of impaired left ventricular ejection fraction--comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP)Thomas Mueller, Alfons Gegenhuber, Werner Poelz, et al.
Clinical Laboratory|April 13, 2004
Comparison of the automated AxSYM and ADVIA centaur immunoassays for homocysteine determinationMeinhard Haltmayer, Thomas Mueller, Alfons Gegenhuber, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|October 21, 2015
Analytical and clinical evaluation of a rapid quantitative lateral flow immunoassay for measurement of soluble ST2 in human plasmaBenjamin Dieplinger, Margot Egger, Alfons Gegenhuber, et al.
Clinical Chemistry and Laboratory Medicine|September 25, 2004
Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samplesThomas Mueller, Alfons Gegenhuber, Benjamin Dieplinger, et al.
Clinical Biochemistry|March 11, 2009
Prognostic value of increased adiponectin plasma concentrations in patients with acute destabilized heart failureBenjamin Dieplinger, Alfons Gegenhuber, Werner Poelz, et al.
Clinical Chemistry|October 15, 2005
Capability of B-type natriuretic peptide (BNP) and amino-terminal proBNP as indicators of cardiac structural disease in asymptomatic patients with systemic arterial hypertensionThomas Mueller, Alfons Gegenhuber, Benjamin Dieplinger, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 8, 2006
B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failureAlfons Gegenhuber, Thomas Mueller, Benjamin Dieplinger, et al.
Clinical Biochemistry|August 2, 2015
Plasma concentrations of novel cardiac biomarkers before and after hemodialysis sessionThomas Mueller, Alfons Gegenhuber, Gert Kronabethleitner, et al.
Pageof 3